Severe respiratory infections are characterized by elevated inflammation and generation of reactive oxygen species (ROS) which may lead to a decrease in antioxidants such as vitamin C and a higher requirement for the vitamin. Administration of intravenous vitamin C to patients with pneumonia and sepsis appears to decrease the severity of the disease and potentially improve survival rate. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes pneumonia, sepsis and acute respiratory distress syndrome (ARDS) in severe cases, and is referred to as coronavirus disease 2019 (COVID-19). Patients with COVID-19 infection also appear to have depleted vitamin C status and require additional supplementation of vitamin C during the acute phase of the disease. To date there have been 12 vitamin C and COVID-19 trials published, including five randomised controlled trials (RCTs) and seven retrospective cohort studies. The current level of evidence from the RCTs suggests that intravenous vitamin C intervention may improve oxygenation parameters, reduce inflammatory markers, decrease days in hospital and reduce mortality, particularly in the more severely ill patients. High doses of oral vitamin C supplementation may also improve the rate of recovery in less severe cases. No adverse events have been reported in published vitamin C clinical trials in COVID-19 patients. Upcoming findings from larger RCTs will provide additional evidence on vitamin supplementation in COVID-19 patients.
【저자키워드】 COVID-19, SARS-CoV2, acute respiratory distress syndrome, Pneumonia, Vitamin C, clinical trials, Sepsis, Randomised controlled trials, intravenous vitamin C, 【초록키워드】 coronavirus disease, SARS-CoV-2, Inflammation, ARDS, coronavirus, randomised controlled trial, clinical trial, Trial, severity, hospital, Infection, inflammatory markers, Intervention, antioxidant, RCT, respiratory infection, adverse event, severe cases, ROS, survival rate, parameters, COVID-19 patients, RCTs, acute respiratory distress, Evidence, dose, Oxygenation, intravenous, acute respiratory syndrome, acute phase, syndrome, severely ill patients, retrospective cohort, FIVE, decrease, Seven, reduce mortality, IMPROVE, reported, the disease, elevated, characterized, appear, less, cause, reduce, reactive oxygen specy, patients with pneumonia, Upcoming, with COVID-19, 【제목키워드】 review, Vitamin, current, Level,